Christopher F. Bigge

Person

Ypsilanti, MI, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of factor Xa and other serine proteases involved in the...
- Patent number 7,407,974
- Issue date Aug 5, 2008
- Pfizer Inc.
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of factor Xa and other serine proteases involved in the...
- Patent number 7,030,141
- Issue date Apr 18, 2006
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of inhibiting amyloid protein aggregation and imaging amyloi...
- Patent number 6,972,287
- Issue date Dec 6, 2005
- Pfizer Inc.
- Corinne Elizabeth Augelli-Szafran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of inhibiting amyloid protein aggregation and imaging amyloi...
- Patent number 6,949,575
- Issue date Sep 27, 2005
- Pfizer Inc.
- Nancy Sue Barta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinoxalinedione derivatives, their preparation and use
- Patent number 6,703,391
- Issue date Mar 9, 2004
- Neurosearch A/S
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antidiabetic agents
- Patent number 6,696,474
- Issue date Feb 24, 2004
- Warner Lambert Co. LLC.
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Subtype-selective NMDA receptor ligands and the use thereof
- Patent number 6,534,522
- Issue date Mar 18, 2003
- Warner-Lambert Company
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-substituted piperidine analogs and their use as subtype-selective...
- Patent number 6,534,525
- Issue date Mar 18, 2003
- Warner-Lambert & Company
- Christopher F. Bigge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-substituted piperidine analogs and their use as subtype selective...
- Patent number 6,448,270
- Issue date Sep 10, 2002
- Warner-Lambert Company
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Subtype-selective NMDA receptor ligands and the use thereof
- Patent number 6,218,404
- Issue date Apr 17, 2001
- Warner-Lambert Co.
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glutamate (ampa/kainate) receptor antagonists: N-substituted fused...
- Patent number 6,197,771
- Issue date Mar 6, 2001
- Warner-Lambert Company
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-substituted piperidine analogs and their use as subtype selective...
- Patent number 6,130,234
- Issue date Oct 10, 2000
- Warner-Lambert Company
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-substituted piperidine analogs and their use as subtype-selective...
- Patent number 6,124,317
- Issue date Sep 26, 2000
- Warner-Lambert Company
- Christopher F. Bigge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-substituted piperidine analogs and their use as subtype selective...
- Patent number 6,124,323
- Issue date Sep 26, 2000
- Warner-Lambert Company
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glutamate (ampa/kainate) receptor antagonists: N-substituted fused...
- Patent number 6,057,313
- Issue date May 2, 2000
- Warner-Lambert Company
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Excitatory amino acid antagonists: fused-azacyclic quinoxalinedione...
- Patent number 5,968,928
- Issue date Oct 19, 1999
- Warner-Lambert Company
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical composition and a method for treating neurodegenerat...
- Patent number 5,942,513
- Issue date Aug 24, 1999
- Warner-Lambert Company
- Christopher Franklin Bigge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating neurodegenerative diseases using an AMPA excitat...
- Patent number 5,767,119
- Issue date Jun 16, 1998
- Warner-Lambert Company
- Christopher Franklin Bigge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glutamate receptor antagonists: fused cycloalkylouinoxalinediones
- Patent number 5,721,234
- Issue date Feb 24, 1998
- Warner-Lambert Company
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glutamate (NMDA) receptor antagonists
- Patent number 5,668,121
- Issue date Sep 16, 1997
- Warner-Lambert Company
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical composition for and a method of using a combination...
- Patent number 5,627,168
- Issue date May 6, 1997
- Warner-Lambert Company
- Christopher F. Bigge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glutamate (NMDA) receptor antagonists
- Patent number 5,489,717
- Issue date Feb 6, 1996
- Warner-Lambert Company
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical composition for and a method of using a combination...
- Patent number 5,407,935
- Issue date Apr 18, 1995
- Warner-Lambert Company
- Christopher F. Bigge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives of 2-carboxyindoles having pharmaceutical activity
- Patent number 5,284,862
- Issue date Feb 8, 1994
- Warner-Lambert Company
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-substituted .alpha.-amino acids and derivatives thereof having ph...
- Patent number 5,179,085
- Issue date Jan 12, 1993
- Warner-Lambert Company
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted alpha-amino acids having pharmaceutical activity
- Patent number 5,175,153
- Issue date Dec 29, 1992
- Warner-Lambert Company
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polycyclic amines useful as cerebrovascular agents
- Patent number 5,071,853
- Issue date Dec 10, 1991
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antimicrobial and antitumor phenazine carboxaldehydes and derivatives
- Patent number 4,657,909
- Issue date Apr 14, 1987
- Warner-Lambert Company
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy...
- Publication number 20100029710
- Publication date Feb 4, 2010
- PFIZER PRODUCTS INC.
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE...
- Publication number 20090221546
- Publication date Sep 3, 2009
- Pfizer Inc.
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of Factor XA and Other Serine Proteases Involved in the...
- Publication number 20080287674
- Publication date Nov 20, 2008
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of fractor Xa and other serine proteases involved in the...
- Publication number 20050250815
- Publication date Nov 10, 2005
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of inhibiting amyloid protein aggregation and imaging amyloi...
- Publication number 20040220235
- Publication date Nov 4, 2004
- Corinne Elizabeth Augelli-Szafran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of inhibiting amyloid protein aggregation and imaging amyloi...
- Publication number 20030220382
- Publication date Nov 27, 2003
- Nancy Sue Barta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIDIABETIC AGENTS
- Publication number 20030220381
- Publication date Nov 27, 2003
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antidiabetic agents
- Publication number 20030171377
- Publication date Sep 11, 2003
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of factor Xa and other serine proteases involved in the...
- Publication number 20030162787
- Publication date Aug 28, 2003
- Christopher Franklin Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Subtype-selective NMDA receptor ligands and the use thereof
- Publication number 20030144319
- Publication date Jul 31, 2003
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL QUINOXALINEDIONE DERIVATIVES, THEIR PREPARATION AND USE
- Publication number 20030114422
- Publication date Jun 19, 2003
- CHRISTOPHER F. BIGGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-Substituted piperidine analogs and their use as subtype selective...
- Publication number 20030105133
- Publication date Jun 5, 2003
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Subtype-selective NMDA receptor ligands and the use thereof
- Publication number 20010051633
- Publication date Dec 13, 2001
- Christopher F. Bigge
- C07 - ORGANIC CHEMISTRY

Christopher F. Bigge

Person

Patents Grantslast 30 patents

Inhibitors of factor Xa and other serine proteases involved in the...

Inhibitors of factor Xa and other serine proteases involved in the...

Method of inhibiting amyloid protein aggregation and imaging amyloi...

Method of inhibiting amyloid protein aggregation and imaging amyloi...

Quinoxalinedione derivatives, their preparation and use

Antidiabetic agents

Subtype-selective NMDA receptor ligands and the use thereof

2-substituted piperidine analogs and their use as subtype-selective...

4-substituted piperidine analogs and their use as subtype selective...

Subtype-selective NMDA receptor ligands and the use thereof

Glutamate (ampa/kainate) receptor antagonists: N-substituted fused...

4-substituted piperidine analogs and their use as subtype selective...

2-substituted piperidine analogs and their use as subtype-selective...

4-substituted piperidine analogs and their use as subtype selective...

Glutamate (ampa/kainate) receptor antagonists: N-substituted fused...

Excitatory amino acid antagonists: fused-azacyclic quinoxalinedione...

Pharmaceutical composition and a method for treating neurodegenerat...

Method of treating neurodegenerative diseases using an AMPA excitat...

Glutamate receptor antagonists: fused cycloalkylouinoxalinediones

Glutamate (NMDA) receptor antagonists

Pharmaceutical composition for and a method of using a combination...

Glutamate (NMDA) receptor antagonists

Pharmaceutical composition for and a method of using a combination...

Derivatives of 2-carboxyindoles having pharmaceutical activity

N-substituted .alpha.-amino acids and derivatives thereof having ph...

Substituted alpha-amino acids having pharmaceutical activity

Polycyclic amines useful as cerebrovascular agents

Antimicrobial and antitumor phenazine carboxaldehydes and derivatives

Patents Applicationslast 30 patents

COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy...

INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE...

Inhibitors of Factor XA and Other Serine Proteases Involved in the...

Inhibitors of fractor Xa and other serine proteases involved in the...

Method of inhibiting amyloid protein aggregation and imaging amyloi...

Method of inhibiting amyloid protein aggregation and imaging amyloi...

ANTIDIABETIC AGENTS

Antidiabetic agents

Inhibitors of factor Xa and other serine proteases involved in the...

Subtype-selective NMDA receptor ligands and the use thereof

NOVEL QUINOXALINEDIONE DERIVATIVES, THEIR PREPARATION AND USE

4-Substituted piperidine analogs and their use as subtype selective...

Subtype-selective NMDA receptor ligands and the use thereof